![]() |
|
|
Vol. 285, Issue 2, 573-578, May 1998
Departments of
Internal Medicine and Surgery (I.G.) and
Division of
Gastroenterology (L-D.W., M.H., R.H., J.D.V.), University of Michigan
Medical Center, Ann Arbor, Michigan
We previously demonstrated that the histamine H2 receptor can activate
both adenylate cyclase (AC) and phospholipase C (PLC) signaling
pathways via separate GTP- dependent mechanisms. We examined whether H2
receptor-specific peptides corresponding to the amino (N) or carboxyl
terminus (C) of the second (2i) or third (3i) intracytoplasmic loops or
the carboxyl terminal tail (P4iN) could effect histamine- stimulated AC
and PLC activity in cell membranes prepared from HEPA cells stably
transfected to express the canine H2 histamine receptor cDNA. Tiotidine
binding and basal signaling were not altered by the synthetic peptides.
H2P2iN, H2P2iC, H2P3iN and H2P4iN did not effect histamine stimulated AC activity although H2P3iC (10
4 M)
significantly inhibited this parameter (65.6 ± 7.2% of maximal stimulation) (n = 6). Combination of the five
peptides (H2P2iN, H2P2iC, H2P3iN, H2P3iC and H2P4iN) abolished
histamine stimulated AC activity. Although all of the peptides
inhibited histamine-stimulated PLC activity to a moderate degree
individually, H2P3iC (10
4 M) had the greatest
effect, decreasing PLC activation to 20.8 ± 6.3% of maximal
stimulation (IC50 = 7.5 × 10
7 M) (n = 6). H2P3iC
and the peptide combination did not alter, forskolin, GTP
s or
epinephrine-stimulated AC activity nor GTP
s and
vasopressin-stimulated PLC. These studies demonstrate that both the
second and third intracytoplasmic loops of the histamine H2 receptor
are linked to separate signaling pathways in a differential manner.